Can surgical management of bone metastases improve quality of life among women with gynecologic cancer?

Table 1 Clinical characteristics of 18 patients in current study

Patient number	Age	Primary tumor	FIGO stage	Treatment for primary tumor	Interval to bone metastasis (month)	Site of bone metastasis	Other site of metastasis	Indication for orthopedic surgery	Therapy for bone metastasis after surgery	VAS (Pre/post-operative)	ECOG (Pre/post-operative)	Follow-up from orthopedic surgery (month)	Status
1	59	EC	IVA	Chemo + RT	37	Sacrum		IP	RT	6/1	3/1	10	DOD
2	68	EC	IIIB	Surg + Chemo	9	Pubic bone		IP	CT	4/0	2/1	30	DOD
3	48	OC	IIIC	Chemo	22	Humerus		PF		5/1	2/1	8	DOD
4	75	OC	IVB	Chemo + RT	at diagnosis	Spine/T3		PF + SCC		4/1	4/2	6	DOD
5	51	EC	IVB	Surg + Chemo	19	Spine/T5	Lung	SCC		6/2	3/3	13	DOD
6	63	OC	IIIB	RT	8	Spine/L2,3		IP		8/4	4/3	11	DOD
7	55	CC	IIB	Surg + Chemo	16	Femur		PF	RT	4/3	4/2	15	DOD
8	55	EC	IIIC	Surg + Chemo + RT	26	Spine/L3		IP		4/1	3/2	28	DOD
9	45	EC	IVB	Chemo + RT	at diagnosis	Spine/T12	Liver	SCC		7/2	3/4	3	DOD
10	55	EC	IVA	Surg + Chemo	16	Spine/L3	Liver	IP		6/8	4/2	16	DOD
11	55	EC^❖	IIA	Surg + Chemo	39	Femur		IP	CT	6/1	3/1	34	NED
12	58	EC	II	Surg + Chemo	48	Acetabulum*/L1		IP		8/3	4/4	4	DOD
13	46	CC	IIB	Surg + Chemo + RT	25	Pubic bone		IP		7/3	1/2	6	DOD
14	35	CC	IIIB	Chemo + RT	14	Sacrum*/Ilium		IP	RT	9/1	4/2	6	DOD
15	76	EC	IIIB	Surg + Chemo + RT	10	Spine/L3	Lung	IP	RT	6/4	3/4	4	DOD
16	56	EC^❖	IB	Surg + Chemo	12	Femur		PF		4/1	4/2	24	AWD
17	46	CC	IIIB	Chemo + RT	20	Femur		PF	CT	5/0	3/1	20	NED
18	47	CC	IIB	Surg + Chemo + RT	27	Humerus*/Ilium		PF	RT	6/1	2/4	5	DOD

AWD, alive with disease; CC, cervical cancer; Chemo, chemotherapy; DOD, died of disease; EC, endometrial carcinoma; EC^❖, uterine leiomyosarcoma; IP, intractable pain; NED, no evidence of disease; OC, ovarian carcinoma; PF, pathological fractures; RT, radiotherapy; SCC, spinal cord compression; Surg, surgery.
*Indicates the operation site.

ISSN: 1477-7819